journal article·2023-07

Functionalized Rhodium Nanoparticles as Antimicrobial Agents for Treatment of Drug‐Resistant Skin and Soft Tissue Infections

Qingqin Tan, Zhenxing Chen, Lei Liu, Xi Huang

Advanced Healthcare Materials· Volume 12· Issue 19
Publisher page

Abstract

Abstract Skin and soft tissue infections (SSTIs) are among the most common bacterial infections reported in outpatients. Drug‐resistant bacteria are the major cause of treatment failure and increased mortality rate in patients with SSTIs, posing significant challenges to human health. In this study, new‐generation rhodium nanoplates (RhNPs) and glycol chitosan‐ and polydopamine‐functionalized RhNPs (Rh@GCS) are developed for the treatment of drug‐resistant SSTIs. RhNPs exhibited favorable antibacterial activity against methicillin‐resistant Staphylococcus aureus (MRSA) and Ag‐resistant MRSA. The modified Rh@GCS exhibited enhanced antibacterial activity and can directly kill various drug‐resistant bacteria by increasing the permeability of cell membranes, including gram‐positive MRSA and gram‐negative multidrug‐resistant Escherichia coli (E.coli) and Pseudomonas aeruginosa (PA). Moreover, Rh@GCS effectively inhibited bacterial growth and promoted the healing of skin lesions in MRSA‐induced SSTI mouse models. These results suggest that Rh@GCS is a promising nonantibiotic antimicrobial agent for the treatment of drug‐resistant SSTIs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Bacterial biofilms and quorum sensing · Antimicrobial agents and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Clinical Research Center for Infectious Disease Shenzhen Third People's Hospital; the Second Affiliated Hospital of Southern University of Science and Technology Shenzhen Guangdong Province 518112 China

Center for Infection and Immunity and Guangdong Provincial Key Laboratory of Biomedical Imaging the Fifth Affiliated Hospital of Sun Yat‐sen University Zhuhai Guangdong Province 519000 China

Kingcell Regenerative Medicine (Guangdong) Co. Zhuhai Guangdong Province 519000 China

Funding

National Natural Science Foundation of China

References (42)

Show source-provided references
1. 10.1080/14737167.2018.145014210.1080/14737167.2018.1450142 ↗
2. 10.1097/QCO.000000000000023910.1097/QCO.0000000000000239 ↗
3. 10.1016/j.idc.2020.10.00810.1016/j.idc.2020.10.008 ↗
4. 10.1093/cid/ciu29610.1093/cid/ciu296 ↗
5. 10.1007/s11908-019-0670-010.1007/s11908-019-0670-0 ↗
6. 10.1097/QCO.000000000000052910.1097/QCO.0000000000000529 ↗
7. 10.4314/ahs.v20i3.1210.4314/ahs.v20i3.12 ↗
8. 10.3390/molecules2524584810.3390/molecules25245848 ↗
9. 10.1002/smll.20200043610.1002/smll.202000436 ↗
10. 10.1016/S1473-3099(18)30605-410.1016/S1473-3099(18)30605-4 ↗
11. 10.1016/S1473-3099(17)30753-310.1016/S1473-3099(17)30753-3 ↗
12. 10.1016/j.addr.2013.07.01110.1016/j.addr.2013.07.011 ↗
13. 10.1021/acsomega.8b0243810.1021/acsomega.8b02438 ↗
14. 10.1021/acsami.6b0926710.1021/acsami.6b09267 ↗
15. 10.1039/C6TB01122E10.1039/C6TB01122E ↗
16. 10.1021/acs.chemmater.8b0066710.1021/acs.chemmater.8b00667 ↗
17. 10.1021/acsami.8b1198010.1021/acsami.8b11980 ↗
18. 10.1021/acsami.7b1196910.1021/acsami.7b11969 ↗
19. 10.1021/acsami.8b0146310.1021/acsami.8b01463 ↗
20. 10.1016/j.msec.2014.08.03110.1016/j.msec.2014.08.031 ↗
21. 10.3390/nano1002029210.3390/nano10020292 ↗
22. 10.1016/j.scitotenv.2022.15572010.1016/j.scitotenv.2022.155720 ↗
23. 10.3390/nano1108208610.3390/nano11082086 ↗
24. 10.1016/j.ijantimicag.2015.03.01410.1016/j.ijantimicag.2015.03.014 ↗
25. 10.3390/jfb1104007610.3390/jfb11040076 ↗
26. 10.1038/s41565-021-00929-w10.1038/s41565-021-00929-w ↗
27. 10.1038/s41565-017-0013-y10.1038/s41565-017-0013-y ↗
28. 10.1021/acsnano.8b0269810.1021/acsnano.8b02698 ↗
29. 10.1039/C9RA00214F10.1039/C9RA00214F ↗
30. 10.1186/s12951-018-0348-z10.1186/s12951-018-0348-z ↗
31. 10.1021/acsami.8b1287310.1021/acsami.8b12873 ↗
32. 10.1016/j.biomaterials.2016.11.04510.1016/j.biomaterials.2016.11.045 ↗
33. 10.1002/smll.20150141210.1002/smll.201501412 ↗
34. 10.1016/j.actbio.2018.01.02210.1016/j.actbio.2018.01.022 ↗
35. 10.1021/acs.nanolett.8b0232510.1021/acs.nanolett.8b02325 ↗
36. 10.1186/s12951-018-0348-z10.1186/s12951-018-0348-z ↗
37. 10.1186/s12992-017-0233-910.1186/s12992-017-0233-9 ↗
38. 10.1186/s13073-020-00825-310.1186/s13073-020-00825-3 ↗
39. 10.1002/smll.20120145510.1002/smll.201201455 ↗
40. 10.1016/j.biomaterials.2022.12165210.1016/j.biomaterials.2022.121652 ↗
41. 10.1002/smll.20200752210.1002/smll.202007522 ↗
42. 10.1016/S0305-4179(00)00140-610.1016/S0305-4179(00)00140-6 ↗